The Latest Cardiac and Vascular News
TEL AVIV, ISRAEL–(Marketwired – August 22, 2017) – InspireMD, Inc. (NYSE American: NSPR) (NYSE MKT: NSPR) (“InspireMD” or the “Company”), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced it received a letter from the NYSE […]
Updated to clarify that MDT officers and directors were compensated for excise-tax based liabilities related to stock options, and not for capital gains. Medtronic (NYSE:MDT) shareholders seeking to sue the company claiming they were harmed by its $50 billion corporate inversion […]
COLORADO SPRINGS, Colo., Aug. 10, 2017 (GLOBE NEWSWIRE) — The Spectranetics Corporation (NASDAQ:SPNC) (“the Company”), a developer and manufacturer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, today announced the occurrence of a Fundamental Change, […]
Amsterdam, the Netherlands and Colorado Springs, CO, U.S. – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of The Spectranetics Corporation (NASDAQ: SPNC), a U.S.-based global leader in vascular intervention and lead management […]
REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc. today announced that Horizon Blue Cross Blue Shield of New Jersey (Horizon BCBSNJ), Blue Cross Blue Shield of Arizona, Blue Cross of Idaho and Blue Cross Blue Shield of Kansas City have each issued a positive […]
ALAMEDA, Calif., Aug. 8, 2017 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on interventional therapies, today reported financial results for the second quarter ended June 30, 2017. Revenue of $80.6 million in the second quarter of 2017, an increase of 23.8%, or […]
DALLAS, Aug. 9, 2017 /PRNewswire/ — Two researchers have been awarded grants that could help uncover the next breakthrough in heart-health research, the American Heart Association and The Paul G. Allen Frontiers Group announced Wednesday. Suneel Apte at the Cleveland Clinic and Jeffrey Holmes at the University […]
MURRAY HILL, N.J. and FRANKLIN LAKES, N.J., Aug. 8, 2017 /PRNewswire/ — C. R. Bard, Inc. (NYSE: BCR) (“Bard”) and Becton, Dickinson and Company (NYSE: BDX) (“BD”) today announced the results of Bard’s special meeting of shareholders, held on August 8, 2017 and at which a quorum was present, […]
WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, today reported financial results for the quarter ended June 30, 2017. Recent Highlights and Accomplishments Revenue of $2.3 million in the second quarter 2017 […]
CeloNova BioSciences Announces Financing Arrangement with Congruent Investment Partners and SWK Holdings Corporation Proceeds to Support Company Growth, Ongoing Clinical Trial Enrollment and New Product Initiatives CeloNova BioSciences, Inc. (CeloNova), a medical device company that develops, manufactures and markets a […]
